Evidence map›Paper›PMID 30203854›Full record

ArticleEquine veterinary journal2019

Efficacy of inhaled budesonide for the treatment of severe equine asthma.

J P Lavoie, M Leclere, N Rodrigues, K R Lemos, C Bourzac, J Lefebvre-Lavoie, G Beauchamp, B Albrecht

Open access · hybridAbstract readClinical Trial, Veterinary
In one paragraph

Article in Equine veterinary journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Decision Making in Severe Equine Asthma-Diagnosis and Monitoring.Animals : an open access journal from MDPI · 2023
    Review
  4. Review
  5. Review
  6. A CONSORT-guided, randomized, double-blind, controlled pilot clinical trial of inhaled lidocaine for the treatment of equine asthma.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2022
    Article
  7. Article
  8. Glucocorticoid treatment in horses with asthma: A narrative review.Journal of veterinary internal medicine · 2021
    Review
  9. Article
  10. Article
  11. Comparative Review of Asthma in Farmers and Horses.Current allergy and asthma reports · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

J P LavoieDepartment of Clinical Sciences, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.ORCID http://orcid.org/0000-0003-4655-2102
M LeclereDepartment of Clinical Sciences, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
N RodriguesDepartment of Clinical Sciences, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
K R LemosDepartment of Clinical Sciences, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
C BourzacDepartment of Clinical Sciences, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
J Lefebvre-LavoieDepartment of Clinical Sciences, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
G BeauchampDepartment of Veterinary Biomedicine, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
B AlbrechtBoehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany.
Université de Montréal · CABoehringer Ingelheim (Germany) · DE

Funding

Boehringer Ingelheim Vetmedica GmbH
6 · The paper itself

Abstract

backgroundCorticosteroids are the most potent drugs for the control of severe equine asthma, but adverse effects limit their chronic systemic administration. Inhaled medications allow for drug delivery directly into the airways, reducing the harmful effects of these drugs.

objectivesTo evaluate the efficacy of inhaled budesonide specifically formulated for the equine use and administered by a novel inhalation device in horses with severe asthma. STUDY

designExperimental studies in horses with naturally occurring asthma with cross-over, randomised, blinded experimental designs.

methodsIn Study 1, budesonide (1800 μg twice daily) administered using a novel Respimat

resultsIn Study 1, there was a marked and significant improvement in the lung function of all horses treated with budesonide and dexamethasone. Neutrophil percentages in bronchoalveolar fluid decreased in all horses treated with dexamethasone and in four of six horses treated with budesonide. Serum cortisol and blood ACTH concentrations decreased with both treatments. In Study 2, there was a significant improvement in the lung function with all dosages of budesonide, and the effects of higher dosages were comparable to those of dexamethasone. Dexamethasone and budesonide at the two higher dosages induced a significant decrease of cortisol concentrations. MAIN LIMITATIONS: The Respimat

conclusionsAdministration of budesonide with the Respimat

Indexed as

AnimalsAnti-Inflammatory AgentsAsthmaBudesonideCross-Over StudiesDose-Response Relationship, DrugHorse DiseasesHorsesRandom AllocationAnti-Inflammatory AgentsBudesonidecorticosteroidcortisolheaveshorserecurrent airway obstruction

Identifiers

PMID30203854
PMCPMC6585971
OpenAlexW2890303540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.